教室紹介

2024年業績集

受賞

  1. Reviewer of the Month (2024) Translational Andrology and Urology 誌
    Translational Andrology and Urology 誌 , 2024 年05月31日

  2. ポスター優秀賞
    第11回泌尿器画像診断·治療技術研究会(JSURT),2024年08月02日

  3. イノベーションアイデアコンテスト2024 最優秀賞
    東京医科歯科大学 統合イノベーション機構, 2024年 09月

  4. 大隅ライフサイエンス研究会奨励賞
    大隅ライフサイエンス研究会,2024年10月

原著

  1. Shimada K, Fujiwara M, Hirahara D, Takaya E, Yoshida S, Fujii Y. Monitoring prostate cancer after low-dose-rate hemigland brachytherapy with delta-radiomics of diffusion-weighted magnetic resonance imaging. Int J Urol.12;31(12);1443-1445. 2024PubMed

  2. Chen W, Yoshida S, Miura N, Fukuda S, Waseda Y, Tanaka H, Fujii Y. Efficacy of docetaxel addition to next-generation androgen receptor-axis-targeted therapies and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: A tumor volume-specific analysis. Int J Urol.12;20(4):361-370. 2024PubMed

  3. Nakamura Y, Yoshida S, Arita Y, Takeshita R, Kimura K, Kobayashi M, Fujiwara M, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Jinzaki M, Fujii Y. The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System. Int J Urol.12;9(3);264-269. 2024 PubMed

  4. Cesare Saitta, Giuseppe Garofano, Jonathan A Afari, Tanaka H, Dattatraya Patil, Kit L Yuen, Luke Wang, Julian Cortes, Margaret F Meagher, Dhruv Puri, Clara Cerrato, Mimi V Nguyen, Kevin Hakimi, Kobayashi M, Fukuda S, Marco Paciotti, Massimo Lazzeri, Giovanni Lughezzani, Nicol`o M Buffi, Fujii Y, Viraj Master, Ithaar H Derweesh. NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma. Clin Genitourin Cancer.12;22(6); 2024PubMed

  5. Yanagi T; Kikuchi H; Takeuchi K; Susa K; Mori T; Chiga M; Yamamoto K; Furukawa A; Kanazawa T; Kato Y; Takahashi N; Suzuki T; Mori Y; Carter BC; Mori M; Nakano Y; Fujiki T; Hara Y; Suzuki S; Ando F; Mandai S; Honda S; Torii S; Shimizu S; Tanaka H; Fujii Y; Rai T; Uchida S; Sohara E. ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease. Kidney Int.11;106(5);887-906. 2024PubMed

  6. Maezawa Y, Kobayashi M, Murakami M, Yamamura A, Naito S, Tanaka H, Yoshida S, Yamada T, Fujii Y. Prolonged hypoglycemia after the resection of pheochromocytoma in a hemodialysis patient. IJU Case Rep.11;7(6);431-433. 2024PubMed

  7. Yoshida S, Maezawa Y, Ishihara K, Inoue N, Tanabe K, Izumi K, Fujiwara M, Toide M, Yamamoto T, Uehara S, Araki S, Inoue M, Takazawa R, Numao N, Ohtsuka Y, Tanaka H, Fujii Y. Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases. Int J Urol.11;31(11);1234-1240. 2024 PubMed

  8. Franklin Liu, Luke Wang, Margaret F Meagher, Jonathan Afari, Cesare Saitta, Sohail Dhanji, Saeed Ghassemzadeh, Aastha Shah, Dhruv Puri, Mimi V Nguyen, Kevin Hakimi, Benjamin Schmeusser, Rachel Greenwald, Alexandra Medline, Fatima Kamal, Adil Ali, Fukuda S, Kobayashi M, Wei Chen, Bo Fan, Aida Y, Maezawa Y, Asai S, Tanaka H, Dattatraya Patil, Fujii Y, Viraj Master, Ithaar H Derweesh. Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC database. Urol Oncol.10;42(10);333.e21-333.e31. 2024 PubMed

  9. Julian A Cortes, Cesare Saitta, Kit L Yuen, Dattatraya Patil, Tanaka H, Dhruv Puri, Jonathan A Afari, Mirha Mahmood, Joshua Matian, Mariam Mansour, Aaron Ahdoot, Luke Wang, Margaret F Meagher, Melis Guer, Mai Dabbas, Mimi V Nguyen, Clara Cerrato, Kobayashi M, Fukuda S, Fujii Y, Viraj Master, Ithaar H Derweesh. Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma. Clin Genitourin Cancer.10;22(5);102126. 2024 PubMed

  10. Tanaka H, Yoshida S, Aoyama S, Ikeda S, Kunieda J, Ohashi K, Fukuda S, Waseda Y, Tanaka H, Fujii Y. A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab. IJU Case Rep.9;7(5);395-398. 2024 PubMed

  11. Tanabe K, Kobayashi S, Maezawa Y, Ishihara K, Inoue N, Izumi K, Fujiwara M, Toide M, Yamamoto T, Uehara S, Araki S, Inoue M, Takazawa R, Numao N, Ohtsuka Y, Tanaka H, Yoshida S, Fujii Y. Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study. Int J Clin Oncol.9;29(9);1302-1310. 2024 PubMed

  12. Horiguchi A, Shinchi M, Hirano Y, Asanuma H, Ishiura Y, Inoue K, Kanematsu A, Tabei T, Tamura Y, Nakajima Y, Moriya K, Yagihashi Y, Fukagai T, Fujii Y. Clinical questions in the Japanese Urological Association's 2024 clinical practice guidelines for urethral strictures. Int J Urol.9;31(9);956-967. 2024 PubMed

  13. Tanaka H, Fukawa Y, Yamamoto K, Tanimoto K, Takemoto A, Mori T, Hasumi H, Kinoshita M, Kanazawa T, Furukawa A, Kimura K, Sato H, Hirakawa A, Fukuda S, Waseda Y, Yoshida S, Steven C Campbell, Fujii Y. Prognostic impact and genomic backgrounds of renal parenchymal infiltration or micronodular spread in non-metastatic clear cell renal cell carcinoma. Mod Pathol.8;12(11);100590. 2024 PubMed

  14. Nakamura Y, Ishikawa Y, Kobayashi M, Fujiwara M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsies. Int J Urol.8;31(11);1263-1268. 2024PubMed

  15. Yokoyama M, Wei Chen, Waseda Y, Fujiwara M, Kato D, Shirakawa T, Shimizu Y, Nenohi T, Matsumoto Y, Okumura T, Urushibara M, Ai M, Fushimi K, Fukagai T, Eto M, Fujii Y, Ishizaka K. Comparisons of in-hospital fee and surgical outcomes between robot-assisted, laparoscopic, and open radical cystectomy. Jpn J Clin Oncol.7;54(7);822-826. 2024PubMed

  16. Fujiwara M, Shimada W, Yokoyama M, Koyanagi A, Shintaku H, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. IJU Case Rep.7;7(4);293-296. 2024 PubMed

  17. Fuyuki F Inagaki, Kano M, Furusawa A, Kato T, Okada R, Fukushima H, Takao S, Okuyama S, Peter L Choyke, Kobayashi H. Near-infrared photoimmunotherapy targeting PD-L1. Cancer Sci.7;115(7);2396-2409. 2024 PubMed

  18. Saito K, Kobayashi M, Yokoyama M, Taguchi T, Kimura K, Akashi T, Fujii Y, Okamoto R. Transjejunal fine-needle biopsy using a forward-viewing echoendoscope. VideoGIE.7;9(7);329-332. 2024 PubMed

  19. Kobayashi M, Matsuoka Y, Uehara S, Tanaka H, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Utility of positive core number on MRI-ultrasound fusion targeted biopsy. Int J Urol.7;31(7);739-746. 2024 PubMed

  20. Fukushima H, Furusawa A, Takao S, Ebaston Thankarajan, Michael P Luciano, Syed Muhammad Usama, Kano M, Okuyama S, Yamamoto H, Suzuki M, Kano M, Peter L Choyke, Martin J Schnermann, Kobayashi H. Near-infrared duocarmycin photorelease from a Treg-targeted ADC. Oncoimmunology.6;13(1);2370544. 2024 PubMed

  21. Kimura K, Yamamoto T, Tsuchiya J, Yoshida S, Yanai S, Onishi I, Fujii Y, Tateishi U. Diagnostic approach of various urethral diseases using multimodal imaging. Abdom Radiol.6;49(12);4416-4436. 2024PubMed

  22. Asai S, Kobayashi M, Fukuda S, Kimura K, Yoshida S, Fujii Y. Significance of atypical nodules upgraded to PI-RADS category 3. Int J Urol.6;31(6);693-695. 2024 PubMed

  23. Cesare Saitta, Jonathan A Afari, Dattatraya Patil, Tanaka H, Kit L Yuen, Luke Wang, Julian Cortes, Franklin Liu, Mirha Mahmood, Joshua Matian, Mariam Mansour, Dhruv Puri, Clara Cerrato, Mimi V Nguyen, Kevin Hakimi, Kobayashi M, Fukuda S, Margaret F Meagher, Fujii Y, Viraj Master, Ithaar H Derweesh. Association of Elevated C-Reactive Protein with Worsened Outcomes. Clin Genitourin Cancer.6;22(3);102098. 2024 PubMed

  24. Kimura G, Fujii Y, Osawa T, Uchitomi Y, Honda K, Kondo M, Otani A, Wako T, Kawai D, Mitsuda Y, Sakashita N, Shinohara N. Therapy-related expectations/concerns of patients with metastatic RCC. Cancer Med.6;13(11);e7196. 2024 PubMed

  25. Fang K, Fang DL, Yu H, Chen YA, Yu PZ, Wang ZF, Zhang RB, Yang W, Tao L, Fukushima H, Dong Y, Han CH. microRNA-mRNA regulatory network of solasonine in bladder cancer. Transl Androl Urol.5;13(5);812-827. 2024 PubMed

  26. Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Nishiyama N, Kimura T, Yamashita S, Kitamura H, Miyake H. Prognostic outcomes after second-line TKI therapy. Int J Urol.5;31(5);526-533. 2024PubMed

  27. Kimura G, Fujii Y, Honda K, Osawa T, Uchitomi Y, Kondo M, Otani A, Wako T, Kawai D, Mitsuda Y, Sakashita N, Shinohara N. Financial Toxicity in Japanese Patients with Metastatic RCC. Cancers (Basel).5;16(10);1904. 2024 PubMed

  28. Toide M, Tanaka H, Kobayashi M, Fujiwara M, Nakamura Y, Fukuda S, Kimura K, Waseda Y, Yoshida S, Tateishi U, Fujii Y. Stepwise CT/MRI algorithm for fat-poor angiomyolipoma. Int J Urol.4;31(7);778-784. 2024PubMed

  29. Cesare Saitta, Jonathan A Afari, Arman Walia, Dattatraya Patil, Tanaka H, Kevin Hakimi, Luke Wang, Margaret F Meagher, Franklin Liu, Mimi V Nguyen, Dhruv Puri, Clara Cerrato, Ava Saidian, Kobayashi M, Fukuda S, Fujii Y, Viraj Master, Ithaar H Derweesh. BMI paradox in renal cortical tumors. Urol Oncol.4;42(4);119.e1-119.e16. 2024PubMed

  30. Fujiwara M, Tanaka H, Kobayashi M, Nakamura Y, Bo Fan, Ishikawa Y, Fukuda S, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Fujii Y. Neoadjuvant chemoradiotherapy followed by radical cystectomy. Clin Genitourin Cancer.4;22(2);193-200.e1. 2024 PubMed

  31. Fukushima H, Takao S, Furusawa A, Vladimir Valera Romero, Sandeep Gurram, Kato T, Okuyama S, Kano M, Peter L Choyke, Kobayashi H. Near-infrared photoimmunotherapy targeting Nectin-4. Cancer Lett.3;585;216606. 2024 PubMed

  32. Ishikawa Y, Tanaka H, Fujiwara M, Nakamura Y, Fukuda S, Waseda Y, Yoshida S, Yokoyama M, Fujii Y. Intraoperative hypotension during TURBT with oral 5-ALA. Int J Urol.3;31(3);238-244. 2024PubMed

  33. Mori K, Hatakeyama S, Enokida H, Miyake H, Kikuchi E, Nishiyama H, Ichikawa T, Kamai T, Kaji Y, Kume H, Kondo T, Matsuyama H, Masumori N, Kawauchi A, Takenaka A, Uemura H, Eto M, Nonomura N, Fujii Y, Hinotsu S, Ohyama C. JUA Guidelines for UTUC 2023. Int J Urol.3;31(3);194-207. 2024 PubMed

  34. Tateishi U, Kimura K, Tsuchiya J, Kano D, Watabe T, Nonomura N, Saito K, Yokoyama K, Yamagiwa K, Adachi T, Kojima Y, Yoshida S, Fujii Y. Phase I/IIa trial of 18F-PSMA-1007 PET/CT. Jpn J Clin Oncol.3;54(3);282-291. 2024 PubMed

  35. Murakami M, Hara K, Ikeda K, Horino M, Okazaki R, Niitsu Y, Takeuchi A, Aoki J, Shiba K, Tsujimoto K, Komiya C, Nakamura Y, Kurata M, Akashi T, Fujii Y, Yamada T. Tumor heterogeneity of aldosterone-producing adenoma. Hypertension.2;81(2);361-371. 2024PubMed

  36. Fan Bo, Yokoyama M, Kobayashi M, Nakamura Y, Fujiwara M, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. eGFR decrease after nephrectomy. Int J Urol.2;31(2);119-124. 2024PubMed

  37. Kataoka M, Yokoyama M, Waseda Y, Ito M, Kobayashi M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Tanaka H, Yoshida S, Masuda H, Fujii Y. LUTS deterioration after AUS implantation. Low Urin Tract Symptoms.1;16(1);e12507. 2024 PubMed

講演· 口頭発表等

  1. Waseda Y. The Importance of Assessing LUTS beyond Incontinence: Decrease in Urinary Incontinence Distress and Emergence of OAB Symptoms After Artificial Urinary Sphincter Implantation. The 29th Annual Meeting of the Korean Continence Society 2024.09.28

  2. Tanaka H. The Emergent Role of Theranostics in Renal Cell Carcinoma. UAA annual congress 2024 2024.09.05

  3. Nakamura Y, Ishikawa Y, Matsumoto S, Ikeda R, Yoshitomi K, Kobayashi M, Fujiwara M, Bo Fan, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Can photodynamic diagnosis-guided biopsy replace bladder mapping biopsy. AUA annual meeting 2024 2024.05.06

  4. Wei Chen. Prognostic nomograms incorporating preoperative CRP level for predicting survival outcomes in patients with nonmetastatic clear cell renal cell carcinoma: INMARC study. AUA annual meeting 2024 2024.05.05

  5. Yasujima R, Tanaka H, Tsuchiya J, Hasegawa A, Tanaka H, Kimura T, Suzuki K, Ito T, Ikeda R, Matsumoto S, Yoshitomi K, Kobayashi M, Fujiwara M, Nakamura Y, Wei Chen, Fan Bo, Ishikawa Y, Fukuda S, Waseda Y, Yoshida S, Fujii Y. Exploring the Role of FDG PET/CT in Predicting Pembrolizumab Response for Metastatic Urothelial Carcinoma. "AUA annual meeting 2024 2024.05.05

  6. Izumi K, Tanaka H, Yano M, Takazawa R, Noro A, Tsukamoto T, Yonese J, Okuno T, Sakai　Y, Koga F, Kageyama Y, Saito K, Fujii Y. Real-word outcomes of maintenance chemotherapy versus avelumab therapy after first-line induction chemotherapy for advanced urothelial carcinoma: YUSHIMA study. AUA annual meeting 2024 2024.05.05

  7. Tanaka H, Fujiwara M, Hasegawa A, Tanaka H, Suzuki K, Kimura T, Yasujima R, Ito T, Ikeda R, Matsumoto S, Yoshitomi K, Kobayashi M, Nakamura Y, Fan B, Chen W, Ishikawa Y, Fukuda S, Waseda Y, Yoshida S, Yoshimura R, Kihara K, Fujii Y.. Long-term oncologic outcomes of tetramodal bladder-preservation therapy incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymphnode dissection for muscle-invasive bladder cancer. AUA annual meeting 2024 2024.05.04

  8. Ishikawa Y, Tanaka H, Bo Fan, Kobayashi M, Fujiwara M, Nakamura Y, Fukuda S, Waseda Y, Yoshida S, Fujii Y. Diagnostic performance of fluorescence cystoscopy using oral 5-aminolevulinic acid in transurethral resection of bladder tumor after BCG treatment . AUA annual meeting 2024 2024.05.04

  9. Suzuki K, Ishikawa Y, Tanaka H, Bo Fan, Kobayashi M, Fujiwara M, Nakamura Y, Fukuda S, Waseda Y, Yoshida S, Fujii Y. Diagnostic accuracy of f luorescence cystoscopy using oral 5-aminolevulinic acid in transurethral resection of bladder tumor after chemoradiation therapy for muscle invasive bladder cancer. AUA annual meeting 2024 2024.05.04

  10. Fujiwara M, Hirahara D, Saho T, Takaya E, Hasegawa A, Kimura T, Suzuki K Tanaka H, Ito T, Yasujima R, Ikeda R, Matsumoto S, Yoshitomi K, Kobayashi M, Nakamura Y, Wei Chen, Bo Fan, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Delta-radiomics analysis in comparison to radiomics analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma. AUA annual meeting 2024 2024.05.04

  11. Enomoto K, Yoshida S, Izumi H, Uehara S, Matsuoka Y, Yamamoto K, Hirahara D, Saho T, Takaya E, Fukuda S, Waseda Y, Tanaka H, Ohashi K, Fujii Y. Are there differences in MRI findings between cribriform and non-cribriform cancer? An analysis using radiomics and delta-radiomics. "AUA annual meeting 2024 2024.05.04

  12. Waseda Y. Treatment strategy for reccurent POP after sacrocolpopexy- AUA/JUA International Affiliate Society Meeting- Female Urology. AUA annual meeting 2024 2024.05.03

  13. Tanaka H, Fujiwara M, Hasegawa A, Tanaka H, Suzuki K, Kimura T, Yasujima R, Ito T, Ikeda R, Matsumoto S, Yoshitomi K, Kobayashi M, Nakamura Y, Fan B, Chen W, Ishikawa Y, Fukuda S, Waseda Y, Yoshida S, Yoshimura R, Kihara K, Fujii Y.Tetramodal bladder-preservation therapy incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymphnode dissection for muscle-invasive bladder cancer: long-term oncologic outcomes of 201 patients. EAU annual congress 2024 2024.04.08

  14. Horie T, Fujiwara M, Hasegawa A, Kimura T, Suzuki K, Tanaka H, Ito T, Yasujima R, Ikeda R, Matsumoto S, Yoshitomi K, Kobayashi M, Nakamura Y, Chen W, Fan B, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Radiomics analysis using non-contrast computed tomography for predicting HDU admission in patients with acute pyelonephritis. EAU annual meeting 2024 2024.04.08

  15. Fukuda S, Kobayashi M, Chen Wei, Fujiwara M, Nakamura Y, Ishikawa Y, Nakayama A, Margaret Meagher, Dattatraya Patil, Waseda Y, Tanaka H, Yoshida S, Saito K, Ithaar H Derweesh, Viraj A Master, Fujii Y. Outcomes of partial and radical nephrectomy in patients with pathological T3a upstaging of clinical T1 renal cell carcinoma: an analysis from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. EAU annual congress 2024 2024.04.08

  16. Tanabe K, Kobayashi S, Nagashima K, Yonese J, Ohtsuka Y, Okuno T, Takazawa R, Noro A, Yano M, Tsukamoto T, Saito K, Sakai Y, Koga F, Kageyama Y, Tanaka H, Yoshida S and Fujii Y. The Gustave Roussy Immune Score Predicts Survival Outcome of Patients with Metastatic Urothelial Carcinoma Treated with Pembrolizumab: YUSHIMA study. EAU annual congress 2024 2024.04.07

  17. Kobayashi M, Yoshitomi K, Bo Fan, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Comparison of the utility of worst vs. global Gleason grade group in MRI-US fusion biopsy for predicting postprostatectomy biochemical recurrence. "EAU annual congress 2024 " 2024.04.06

  18. Yoshida S, Kimura K, Ikeda M, Fukui K, Tsuchiya J, Nakamura Y, Waseda Y, Tanaka H, Tateishi U, Fujii Y Quantitative MRI Parameters Providing the Novel Value in Discriminating Muscle-Invasive Bladder Cancer.. The 39th Annual Congress of the European Association of Urology 2024.04.06

  19. Wei Chen. Development and validation of prognostic nomograms and integrated software incorporating preoperative CRP level for predicting survival outcomes in patients with nonmetastatic clear cell renal cell carcinoma: INMARC study. 39th Annual congress of EAU 2024.04.06 33.

  20. Tanaka H, Fujii Y Presurgical systemic therapy and subsequent cytoreductive nephrectomy (CN). EAU annual congress 2024 2024.04.05

  21. Tanaka H, Kobayashi M, Yoshitomi K, Bo Fan, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Transperineal approach is safer than transrectal approach in MRI-ultrasound fusion prostate biopsy: an analysis using propensity score matching. "EAU annual congress 2024 " 2024.04.05

  22. Fujiwara M, Hirahara D, Saho T, Takaya E, Hasegawa A, Kimura T, Suzuki K, Tanaka H, Ito T, Yasujima R, Ikeda R, Matsumoto S, Yoshitomi K, Kobayashi M, Nakamura Y, Wei Chen, Bo Fan, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Delta-radiomics analysis in comparison to radiomics analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma. EAU annual meeting 2024 2024.04.05

  23. Kimura T, Fujiwara M, Matsumoto S, Yoshitomi K, Kobayashi M, Bo Fan, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Takazawa R, Sakai Y, Koga F, Saito K, Yano M, Tsukamoto T, Okuno T, Kageyama Y, Otsuka Y, Nagahama K, Fuji Y. Real-world outcomes of first-line systematic treatment in advanced Upper-Urinary Tract Urothelial Carcinoma patients with renal impairment : YUSHIMA-04 study". EAU annual congress 2024 2024.04.05

  24. Waseda Y, Ikeda R, Matsumoto S, Yoshitomi K, Fan B, Kobayashi M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Tanaka H, Yoshida S, Fujii Y. Optimal timing of surgical intervention after diagnosis of upper urinary tract stones: a perspective from renal function preservation.. 39th Annual congress of EAU 2024.04.04

  25. Matsumoto S. Incidence of potential candidates for kidney-sparing surgery in upper tract urothelial carcinoma : analysis using radical nephroureterectomy specimens. 39th Annual congress of EAU 2024.04.04

  26. Takao S, Furusawa A, Fukushima H, Okuyama S, Kano M, Yamamoto H, Choyke PL, Kobayashi H. F3 targeted near-infrared photoimmunotherapy: The ideal therapeutic approach for numerous malignancies.. AACR Annual Meeting 2024 2024.04

  27. Tanaka H. Presurgical Immune Checkpoint Inhibitors in Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus: Yes or No?. Advancements in Urology: An AUA/JUA Symposium 2024.03.09

  28. Kobayashi M. SessionⅠ: Prostate cancer Panel Discussion: Case Management MRI Guided Fusion Biopsy of the Prostate . Advancements in Urology 2024 AUA/JUA Symposium 2024.03.07

  29. Waseda Y. Treatment strategy for reccurent POP after sacrocolpopexy - AUA/JUA

    30. International Affiliate Society Meeting- Female Urology. AUA annual meeting 2024 2024.05.03

  30. Waseda Y, Ikeda R, Matsumoto S, Yoshitomi K, Fan B, Kobayashi M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Tanaka H, Yoshida S, Fujii Y. Optimal timing of surgical intervention after diagnosis of upper urinary tract stones: a perspective from renal function preservation. 39th Annual congress of EAU 2024.04.04